StockWatch
·
Pharmaceuticals
Board Meeting5 Nov 2026, 11:22 am

Mercury Laboratories Approves Unaudited Q2 FY27 Results

AI Summary

Mercury Laboratories Ltd announced the approval of its unaudited financial results for the quarter and half-year ended September 30, 2026, during a Board Meeting held on November 5, 2026. The meeting commenced at 9:30 a.m. IST and concluded at 11:15 a.m. IST. The company also submitted the Limited Review Report from its statutory auditors.

Key Highlights

  • Board of Directors approved unaudited financial results.
  • Results are for the quarter and half-year ended September 30, 2026.
  • Limited Review Report from auditors was submitted.
  • Board meeting held on November 5, 2026.